Bouman CSC - Search Results

1

Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.

van Grootveld R, van der Beek MT, Janssen NAF, Ergün M, van Dijk K, Bethlehem C, Stads S, van Paassen J, Heunks LMA, Bouman CSC, Reijers MHE, Brüggeman RJ, van de Veerdonk FL, van Bree SHW, van den Berg CHSB, Kuindersma M, Wauters J, Beishuizen A, Verweij PE, Schouten JA; CAPA2.0 study group. van Grootveld R, et al. Among authors: bouman csc. J Crit Care. 2023 Aug;76:154272. doi: 10.1016/j.jcrc.2023.154272. Epub 2023 Feb 16. J Crit Care. 2023. PMID: 36801598 Free PMC article.

2

[Leprosy in The Netherlands in the period 1970-1991].

Post E, chin-A-Lien RA, Bouman C, Naafs B, Faber WR. Post E, et al. Ned Tijdschr Geneeskd. 1994 Sep 24;138(39):1960-3. Ned Tijdschr Geneeskd. 1994. PMID: 7935946 Dutch.

3

Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes.

Bouman CS, van Olden RW, Stoutenbeek CP. Bouman CS, et al. Blood Purif. 1998;16(5):261-8. doi: 10.1159/000014343. Blood Purif. 1998. PMID: 9917534

4

High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion.

Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB. Grootendorst AF, et al. Shock. 1994 Jul;2(1):72-8. doi: 10.1097/00024382-199407000-00014. Shock. 1994. PMID: 7735987

5

Comparison of the efficacy of D-dimer, fibrin degradation products and prothrombin fragment 1+2 in clinically suspected deep venous thrombosis.

Bouman CS, Ypma ST, Sybesma JP. Bouman CS, et al. Thromb Res. 1995 Feb 1;77(3):225-34. doi: 10.1016/0049-3848(95)91610-w. Thromb Res. 1995. PMID: 7740515 Clinical Trial.

6

[Necrotising soft-tissue infections: diagnostics and treatment].

Garssen FP, Goslings JC, Bouman CS, Beenen LF, Visser CE, de Jong VM. Garssen FP, et al. Ned Tijdschr Geneeskd. 2013;157(31):A6031. Ned Tijdschr Geneeskd. 2013. PMID: 23899705 Review. Dutch.

7

Dosing of antimicrobial agents in critically-ill patients with acute kindey injury and continuous venvenous haemofiltration.

Bouman CS. Bouman CS. Acta Clin Belg. 2007;62 Suppl 2:365-70. doi: 10.1179/acb.2007.082. Acta Clin Belg. 2007. PMID: 18284001 Review.

8

Serum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure?

Royakkers AA, van Suijlen JD, Hofstra LS, Kuiper MA, Bouman CS, Spronk PE, Schultz MJ. Royakkers AA, et al. Curr Med Chem. 2007;14(21):2314-7. doi: 10.2174/092986707781696555. Curr Med Chem. 2007. PMID: 17896979 Review.

9

A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury.

Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Bagshaw SM, et al. Nephrol Dial Transplant. 2009 Sep;24(9):2739-44. doi: 10.1093/ndt/gfp159. Epub 2009 Apr 6. Nephrol Dial Transplant. 2009. PMID: 19349297

10

Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.

Hodiamont CJ, Juffermans NP, Bouman CS, de Jong MD, Mathôt RA, van Hest RM. Hodiamont CJ, et al. Int J Antimicrob Agents. 2017 Feb;49(2):204-211. doi: 10.1016/j.ijantimicag.2016.10.022. Epub 2016 Dec 16. Int J Antimicrob Agents. 2017. PMID: 28038961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters